ABSTRACT
This chapter describes the application of nutraceuticals for prevention and treatment of inflammatory–oxidative stress-mediated acute and chronic lung disease states. Acute and chronic exposures to environmental pollution also promote oxidative stress in the lungs. There are many factors that may lead to generation of inflammatory–oxidative stress in the lungs with poor lifestyle and environmental exposures being the prominent one. Globally, around 300 million people are afflicted with asthma, which is a chronic obstructive lung disease that is characterized by airway inflammatory–oxidative stress, increased airway responsiveness, and irregular airflow obstruction. As asthma is a global disease afflicting people of all ages that confronts us with a significant economic burden in treatment costs, it is not a surprise that there are several antioxidant nutraceuticals and natural products available for the prevention and treatment of asthma. Bronchopulmonary dysplasia is a chronic lung disease that affects premature infants who undergo artificial ventilation.
